Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDValion Bio Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$85.00 | -$85.00 | -$85.00 |
| Q2 2026 | 1 | -$408.00 | -$408.00 | -$408.00 |
| Q3 2026 | 1 | -$408.00 | -$408.00 | -$408.00 |
| Q4 2026 | 1 | -$10,200.00 | -$10,200.00 | -$10,200.00 |
| Q1 2027 | 1 | -$13,600.00 | -$13,600.00 | -$13,600.00 |
| Q2 2027 | 1 | -$13,175.00 | -$13,175.00 | -$13,175.00 |
| Q3 2027 | 1 | -$4,675.00 | -$4,675.00 | -$4,675.00 |
| Q4 2027 | 1 | -$3,400.00 | -$3,400.00 | -$3,400.00 |
| Q1 2028 | 1 | -$2,975.00 | -$2,975.00 | -$2,975.00 |
| Q2 2028 | 1 | -$2,975.00 | -$2,975.00 | -$2,975.00 |
| Q3 2028 | 1 | -$2,975.00 | -$2,975.00 | -$2,975.00 |
| Q4 2028 | 1 | -$2,550.00 | -$2,550.00 | -$2,550.00 |
| Q1 2029 | 1 | -$2,550.00 | -$2,550.00 | -$2,550.00 |
| Q2 2029 | 1 | -$2,125.00 | -$2,125.00 | -$2,125.00 |
Valion Bio Inc Earnings Date And Information
Valion Bio Inc last posted its earnings results on Friday, August 14th, 2026. The company reported $-54.25 earnings per share for the quarter, topping analysts' consensus estimates of $-85 by $30.75. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Valion Bio Inc has generated $-8 earnings per share over the last year ($-7.84 diluted earnings per share) and currently has a price-to-earnings ratio of -0.01. Valion Bio Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Valion Bio Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2026 | Q2 2027 | -$85.00 | -$54.25 | 30.75 | N/A | $0 |
| 05/14/2026 | Q1 2027 | -$85.00 | -$55.75 | 29.25 | $1.43 M | $0 |
| 03/30/2026 | Q4 2026 | -$85.00 | $0.00 | N/A | $1.43 M | $-302,000 |
| 11/14/2025 | Q3 2026 | -$102.00 | -$1.97 | 100.03 | $1.26 M | $146.00 K |
| 08/14/2025 | Q2 2026 | N/A | -$2.19 | N/A | $1.13 M | $86.00 K |
| 05/15/2025 | Q1 2026 | N/A | -$65.95 | N/A | $1.07 M | $0 |
| 03/30/2025 | Q4 2025 | N/A | -$2.65 | N/A | $1.33 M | $180.00 K |
| 11/14/2024 | Q3 2025 | -$119.00 | -$3.93 | 115.07 | $780.00 K | $126.00 K |
| 08/14/2024 | Q2 2025 | N/A | -$5.37 | N/A | N/A | $140.00 K |
| 05/15/2024 | Q1 2025 | -$119.00 | -$17.15 | 101.85 | N/A | $334.00 K |
| 03/25/2024 | Q4 2024 | N/A | -$26.01 | N/A | N/A | $357.00 K |
| 11/14/2023 | Q3 2024 | -$119.00 | -$25.15 | 93.85 | N/A | $282.00 K |
| 08/14/2023 | Q2 2024 | N/A | -$121.72 | N/A | N/A | $161.00 K |
| 05/15/2023 | Q1 2024 | -$46.75 | -$178.77 | -132.02 | N/A | $376.00 K |
| 03/31/2023 | Q4 2023 | N/A | -$395.93 | N/A | N/A | $408.00 K |
| 11/14/2022 | Q3 2023 | N/A | -$453.90 | N/A | N/A | $477.00 K |
| 08/15/2022 | Q2 2023 | N/A | -$533.24 | N/A | N/A | $528.00 K |
| 05/16/2022 | Q1 2023 | N/A | -$391.97 | N/A | N/A | $428.00 K |
| 03/31/2022 | Q4 2022 | N/A | -$651.64 | N/A | N/A | $389.00 K |
| 09/29/2021 | Q3 2022 | N/A | -$1,529.76 | N/A | N/A | $277.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Valion Bio Inc Earnings: FAQ's
In the previous quarter, Valion Bio Inc (:VBIO) reported $-54.25 earnings per share (EPS) to beat the analysts' consensus estimate of $-85 by $30.75.
The conference call for Valion Bio Inc's latest earnings report can be listened to online.
The conference call transcript for Valion Bio Inc's latest earnings report can be read online.
Valion Bio Inc (:VBIO) has a recorded net income of $-8,878,000.Valion Bio Inc has generated $-7.84 earnings per share over the last four quarters.
Valion Bio Inc (:VBIO) has a price-to-earnings ratio of -0.01 and price/earnings-to-growth ratio is 0.